News
2d
Zacks.com on MSNHere's Why You Should Add HealthEquity Stock to Your Portfolio NowHealthEquity has experienced significant growth in its HSA offerings. As of Jan. 31, 2025, the company reported 9.9 million HSAs, marking a 14% increase year over year. Additionally, total HSA assets ...
From food banks to crisis shelters, 14 nonprofits recognized for tackling urgent community needsDRAPER, Utah, May 29, 2025 (GLOBE NEWSWIRE) -- The HealthEquity Community Foundation™ today announced ...
4d
Zacks.com on MSNHealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings GrowthHealthEquity (HQY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DRAPER, Utah, May 29, 2025 (GLOBE NEWSWIRE) -- The HealthEquity Community Foundation™ today announced the recipients of its second round of community grants, awarding $35,000 across 14 nonprofit ...
The market expects HealthEquity (HQY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus ...
2d
Investor's Business Daily on MSNHealthEquity Clears Key Benchmark, Hitting 80-Plus RS RatingHealthEquity reached an important technical milestone, with its Relative Strength (RS) Rating jumping into the 80-plus percentile with an upgrade to 83, up from 80 the day before. Please watch the ...
2d
Zacks Investment Research on MSNHims & Hers Stock Falls Despite the Latest Wegovy Availability OfferHims & Hers Health, Inc. HIMS announced that eligible customers can now access six months of prescription-only Wegovy at a ...
In a report released today, Anne Samuel from J.P. Morgan reiterated a Buy rating on Phreesia ( PHR – Research Report ), with a price target of $30.00. The company’s shares closed today at $23.30.
Scotiabank’s Shaun Osborne pointed to global hedge funds reloading on Canadian dollar short positions, ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results